Executive Director
AstraZeneca
Weston, Massachusetts
Annette Bak, Ph.D., MBA leads Advanced Drug Delivery (ADD) at Astra Zeneca, a global organization in Sweden, UK & US, with a mission to transform diverse synthetic modalities into investigational medicines.
Since joining AstraZeneca in 2016, Annette has been instrumental in delivering drug delivery systems and formulations for preclinical & clinical studies, notably for nucleotide-based therapies. She has also built delivery chemistry and intracellular drug delivery capabilities within ADD.
Annette previously worked for Amgen and Merck with responsibility for small molecule and peptide formulations, building outsourcing partnerships in China, in licensing and partnership evaluations, and contributing to getting small molecule therapies to the market.
Annette has published more than 40 articles, has more than 35 invited presentations, and holds several patents for pharmaceutical technologies enabling drug delivery of small molecules and biologics.
A key volunteer in AAPS. She is the President for the association and responsible for leading implementation of the 2021-2025 strategic plan and ensuring that the AAPS communities are thriving. Annette was the 2020 co-recipient of the AAPS Alice E Till Women in Pharmaceutical Science Recognition, honoring women who has made significant contributions to the to the mentorship, advancement, and support of women in the pharmaceutical sciences
Disclosure information not submitted.
Monday, October 17, 2022
3:30 PM – 4:30 PM ET
Wednesday, October 19, 2022
10:30 AM – 11:30 AM ET